Deutsche Bank’s CervoMed CRVO Stock Holding History

Deutsche Bank’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3	Closed	–	–	4943
2019 Q2	$0	Buy	+3	New	+$809	﹤0.01%	5312
2017 Q3	–	Hold	0	–	–	–	4908
2017 Q2	–	Hold	0	–	–	–	4958
2017 Q1	–	Hold	0	–	–	–	4940

Other funds holding CRVO

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Deutsche Bank's CRVO Position: Q3 2019 in Review

Deutsche Bank sold out of CervoMed (CRVO) in Q3 2019, closing a stake of 3 shares.

Deutsche Bank first reported a position in CRVO in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2019.

Deutsche Bank reported no remaining CervoMed position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 3 CervoMed shares in Q3 2019.
Deutsche Bank first reported a position in CervoMed in Q2 2019 and held it in 1 quarter.
Deutsche Bank's CervoMed position peaked at $0 in Q2 2019.
12 funds tracked by Wall St. Rank held CervoMed as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.